We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.
- Authors
Desai, Jayesh; Yassa, Leila; Marqusee, Ellen; George, Suzanne; Frates, Mary C; Chen, Ming Hui; Morgan, Jeffrey A; Dychter, Samuel S; Larsen, P Reed; Demetri, George D; Alexander, Erik K
- Abstract
Sunitinib malate is an oral tyrosine kinase inhibitor recently approved for the treatment of gastrointestinal stromal tumors and renal cell carcinoma. Because the ret proto-oncogene is also inhibited by this agent, clinical evaluation of thyroid function was performed.
- Publication
Annals of internal medicine, 2006, Vol 145, Issue 9, p660
- ISSN
1539-3704
- Publication type
Journal Article
- DOI
10.7326/0003-4819-145-9-200611070-00008